Skip to main content
A promising emerging therapy (RIFAXIMIN)  for the treatment of IBS Diarrhoea & SIBO

A promising emerging therapy (RIFAXIMIN) for the treatment of IBS Diarrhoea & SIBO

Enroll in FDC001

Starts

Offered by FDCRIFABET FDCRIFABET

Key Fact

  • Price Free
  • Language English

Share your Case Studies

Come join our "Learn as you Teach" initiative to democratise healthcare learning by submitting your unique & interesting Case-Studies which will be reviewed by our global medical fraternity as well as an opportunity to be published in leading research journals.

Meet the instructor

Course Staff Image #1

Dr. Philip Abraham

MD, DNB, FCPS, FICP Consultant Gastroenterologist and Hepatologist, P D Hinduja Hospital, and Hinduja Healthcare Surgical, Mumbai. Retired Professor and Head, Department of Gastroenterology, K E M Hospital, Mumbai.

Enroll